Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria
Recruiting now
Conditions studied: Interstitial Lung Disease
In brief
The goal of this registry is to systematically record epidemiological and clinical data throughout the whole interstitial lung disease course - starting with the diagnosis, therapy, follow up of lung function, symptom control, adverse events, medication, survival and death. There are no additional interventions regarding this registry.
Key facts
- Study ID
- NCT06522334
- Run by
- Ludwig Boltzmann Institute for Lung Health
- People needed
- 400
- Starts
- 2024-02-28
- Expected to finish
- 2034-02-28
- Last updated by the study team
- 2025-03-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- diagnosis of interstitial lung disease
- written informed consent
You may not qualify if…
- to not comprehend and rightfully judge participation
Where it is running
- Klinik Hietzing — Vienna, Austria (enrolling)
- Klinik Penzing — Vienna, Austria (enrolling)
- Ludwig Boltzmann Institut for Lung Health — Vienna, Austria (enrolling)
- Klinik Ottakring — Vienna, Austria (enrolling)
- Klinik Floridsdorf — Vienna, Austria (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.